People News

Following its acquisition of Genentech, Roche has announced that Pascal Soriot, currently head of Roche's commercial pharmaceutical operations, will become Genentech's CEO, effective May 1, 2009.

April 16, 2009

4:22 pm

Following its acquisition of Genentech, Roche has announced that Pascal Soriot, currently head of Roche’s commercial pharmaceutical operations, will become Genentech’s CEO, effective May 1, 2009. Soriot succeeds Arthur Levinson, chairman and CEO of Genentech since 1995. Levinson will retain his position as chairman.

Alnara Pharmaceuticals, a pharma manufacturer focused on the treatment of metabolic diseases, announced the promotion of Robert Gallotto to chief business officer. Gallotto was previously SVP, operations and corporate development.

From Our Partners

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.

Partner Content

The new brand.com experience

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

Partner Content

Shifting market trends are transforming how pharma marketers find, target and engage with patients and providers

The Healthcare Marketers Trend Survey shows that, as far as channel usage goes, more growth occurred in newer tactics like non-linear video and streaming audio than in some of the more traditional ones.

A Big C Shift: Rebranding cancer to reflect advances in oncology

Partner Content

A Big C Shift: Rebranding cancer to reflect advances in oncology

Pivoting people’s perception of the disease to match the realities of treatment.